ASCO abstracts now available - 1256484

JimC
Posts:2753

In a couple of weeks 30,000 oncology professionals will gather in Chicago for the annual conference of the American Society of Clinical Oncology, the largest of its kind. The latest research results will be presented and discussed. If you are interested in browsing through the abstracts of those studies, they are now available to view and print: http://abstracts2.asco.org/absttogo.html

JimC
Forum moderator

Forums
Full Archive

Reply # - May 16, 2013, 03:03 PM

JimC
Posts: 2753

Hi Judy,

Not sure I understand. There are 125 abstracts dealing with metastatic lung cancer, and 116 with earlier stage NSCLC, small cell and other thoracic cancers, so in sheer numbers there's quite a bit. On the other hand, I haven't reviewed the abstracts yet so I wouldn't have an opinion on how many of them seem interesting or promising. Of course, some of the abstracts don't include a great deal of information, stating only that results will be presented at ASCO; it's hard to judge how much interest those will generate.

JimC
Forum moderator

Reply # - May 16, 2013, 09:21 PM

Dr West
Posts: 4735

We'll be doing a video program with Drs. Pinder and Pennell on the last day of ASCO that we plan will be turned into podcasts as early as the end of the week of ASCO (around 6/7). We'll try to cover the leading work in lung cancer at this program and then a highlights of ASCO in lung cancer webinar in the first half of July, I think.

-Dr. West

Reply # - May 17, 2013, 12:54 PM

catdander
Posts:

Things I just learned
For those looking specifically for acquired resistance and using a "find" search in the pdf file. Acquired resistance is abbreviated 'AR'. Though I did find that out by searching resistance it wouldn't give me as much with "acquired".

Something else I just learned and will pass along to EGFR mutants though you probably know this, "de novo" in de novo (EGFR) T790M mutations means the mutation isn't from the parents.

I wonder if there will be any pre conclusions on the pd 1 Nivolumab phase III trials.

This is the pdf file/page with all the abstracts on stage IIIb and IV nsclc. http://abstracts2.asco.org/resources/pdfs/AM13_Presented_Lung_Cancer-No…

Reply # - May 17, 2013, 09:28 PM

certain spring
Posts: 762

Thanks Janine and Jim - very handy.
Actually there seem to be quite a few abstracts reporting on early studies of PD-1 drugs, see for eg nos. 8030, 8072, 8008.

Reply # - May 21, 2013, 06:06 PM

laya d.
Posts: 714

Awesome. . .I hope that lots and lots of good results get reported. All fingers and toes are crossed. . .

Thanks Jim for posting...

Laya

Previous PostNext Post